KINGFISHER

Clinical Trials // Diabetic Macular Edema // Michael Altaweel // Past // Jun 12 2019

A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients with Visual Impairment Due to Diabetic Macular Edema (KINGFISHER)

Sponsor: Novartis Pharmaceuticals

clinicaltrials.gov